What is Bioplexus?
BioPlexus is a specialized supplier of medical-grade silicone products, catering to doctors and distributors globally. Their product portfolio encompasses silicone blocks for prosthetics, sheeting for medical procedures, and pads for laboratory applications. Additionally, they offer SpectraFilm adhesive gel sheets for scar treatment. The company's operational focus is on addressing diverse medical requirements with an emphasis on rapid, same-day product delivery.
How much funding has Bioplexus raised?
Bioplexus has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
What's next for Bioplexus?
The substantial expansion capital secured by Bioplexus at this significant Series B/C stage signals a strategic move towards scaling operations and potentially broadening its market reach. This investment is likely to fuel advancements in product development, enhance manufacturing capabilities, and strengthen distribution networks. The company's commitment to same-day delivery suggests an ongoing focus on operational efficiency and customer service, which will be critical as they navigate this growth phase.
See full Bioplexus company page
